Enovis reported $259.38M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Alcidion AUD 1.09M 184K Dec/2025
Ambu A/S DKK 630M 37M Sep/2026
Apollo Hospitals Enterprise Ltd INR 7.25B 382M Mar/2025
Coloplast 2.64B 52M Dec/2025
Convatec Group USD 420.3M 210.35M Dec/2024
Diasorin EUR 91.47M 35.47M Jun/2026
Enovis USD 259.38M 4.35M Sep/2026
Gulf Medical Proj AED 806K 109K Mar/2026
Hoya 2.87B 13.34B Sep/2026
Max Healthcare Institute Limited 5.64B 407M Sep/2026
Med Life RON 26.47M 3.41M Mar/2026
Oriola-kd EUR 13M 3.1M Sep/2025
Rede D'or Sao Luiz BRL 765.86M 738.14M Sep/2026
Siemens Healthineers EUR 1.08B 68M Sep/2026
Sonova Holding CHF 880.2M 300K Jun/2025